Brookline Capital Markets

What Brookline Capital Markets does

Brookline Capital Markets is a New York-based investment banking boutique that operates as a division of Arcadia Securities, LLC, a FINRA/SIPC-registered broker-dealer. Founded in 2013 by three former Lazard and Paramount BioCapital professionals, the firm specializes in healthcare capital markets, serving life sciences, medical technology, diagnostics, and SPAC issuers, with selective mandates in other emerging growth sectors. The firm has executed more than 300 transactions valued at over $35 billion since inception, with repeat clients accounting for more than 70% of its healthcare business.

The firm's product platform spans the full equity capital markets stack: public equity underwriting (IPOs, follow-on offerings, confidentially marketed public offerings, registered direct offerings), private placements (PIPEs, convertible notes, convertible preferred), capital markets and strategic advisory, M&A advisory, and a dedicated SPAC franchise for both IPO underwriting and business combination advisory. Brookline also publishes proprietary equity research on biotechnology and life sciences, including the monthly 'Brookline Brief,' and maintains an institutional sales and trading desk. Securities are offered through its affiliate Arcadia Securities, with Pershing, LLC as clearing firm.

Brookline generates revenue through transaction-based fees on underwriting, placement agent mandates, and advisory retainers, with pricing negotiated deal-by-deal rather than disclosed publicly. Distribution is anchored by a proprietary network of institutional investors, family offices, and high net worth individuals, which the firm describes as its primary differentiator. The firm employs 11–50 professionals led by a senior team averaging 25+ years of Wall Street experience, with Managing Partners drawn from Lazard, BTIG, Cowen, and Truist, supplemented by MDs and senior scientific advisors with PhD and MD credentials.

Name

Brookline Capital Markets

Legal name

Arcadia Securities, LLC (operating as Brookline Capital Markets)

Website

https://brooklinecapmkts.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Brookline Capital Markets is a New York-based healthcare-focused investment banking boutique operating as a division of Arcadia Securities, providing equity underwriting, PIPEs, SPAC services, and advisory to life sciences, medtech, diagnostics, and emerging growth issuers.

Ownership category

akta.pro rank

Product category

Investment Banking (Healthcare)

NAICS

Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523), Other Financial Investment Activities (5239), Portfolio Management and Investment Advice (52394)

SIC

Security Brokers, Dealers & Flotation Companies (6211), Investment Advice (6282)

akta.pro primary industry

Capital Markets Advisory (IPO Readiness, SPAC, ECM/DCM Advisory) (BPAHAOAL)

akta.pro secondary industries

Capital Raising Advisory (Debt/Equity/Private Capital) (BPAHADAG), Capital Raising Advisory (Equity & Equity-Linked) (FSAEAGAC), Equity Capital Advisory (Private Equity Placements, Growth Capital) (BPAHAOAE), Institutional Capital Introduction (LP/Family Office/Endowment Matching) (FSAEALAI)

Keywords

• Healthcare investment banking
• Equity underwriting services
• Private placements PIPEs
• Capital markets advisory
• SPAC underwriting

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Equity Underwriting: IPO underwriting, follow-on offerings, confidentially marketed public offerings (CMPOs), and registered direct offerings for public companies.
2. Private Placements: Private investment in public equity financings (PIPEs) and private placements for cutting-edge healthcare companies.
3. Advisory Services: IPO advisory, capital markets advisory, and strategic advisory services for healthcare corporate clients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Brookline Capital Markets is a healthcare-focused investment banking boutique that provides a full suite of capital markets and advisory services to transformative companies. Core offerings include equity underwriting (IPOs, follow-ons, CMPOs, registered directs), private placements (PIPEs, convertibles, convertible preferred), strategic and M&A advisory, SPAC underwriting and business combination advisory, equity research, and institutional sales and trading. Securities are offered through Arcadia Securities, LLC, and transactions are distributed via the firm's proprietary network of institutional investors, family offices, and high net worth individuals.

Product overview

Brookline Capital Markets is an investment banking boutique offering a comprehensive suite of financing solutions and strategic advisory services to healthcare companies. The firm operates as a platform comprising multiple interconnected services: equity underwriting (IPOs, follow-ons, CMPOs, RDs), private placements (PIPEs), and capital markets advisory form the core public and private capital markets franchise. The firm also maintains an active SPAC franchise and provides equity research coverage on biotechnology and life sciences companies. The Brookline Brief publication serves as a thought leadership and client engagement tool. All services are distributed through the firm's proprietary network of institutional investors, family offices, and high net worth individuals.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Over 300 transactions completed valued at over $35 billion
• +2 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Seven partnerships are on record, tiered minor.

• Columbia UniversityminorStrategic or Co-development PartnerBrookline has a heritage of working with and sourcing investment opportunities from leading research institutions including Columbia University.
• Harvard UniversityminorStrategic or Co-development PartnerBrookline has a heritage of working with and sourcing investment opportunities from leading research institutions including Harvard University.
• Johns Hopkins UniversityminorStrategic or Co-development PartnerBrookline has a heritage of working with and sourcing investment opportunities from leading research institutions including Johns Hopkins University.
• Stanford UniversityminorStrategic or Co-development PartnerBrookline has a heritage of working with and sourcing investment opportunities from leading research institutions including Stanford University.
• B. Dyson Capital AdvisorsminorOthersAffiliate of Brookline Capital Markets and Arcadia Securities, LLC. Brookline Capital Holdings, LLC as Sponsor and B. Dyson Capital Advisors division of Arcadia Securities have completed transactions together.
• Tiberius Capital MarketsminorOthersAffiliate of Brookline Capital Markets and Arcadia Securities, LLC.
• Hermes Capital AdvisorsminorOthersAffiliate of Brookline Capital Markets and Arcadia Securities, LLC.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Oppenheimer & Co. Diversified investment bank with healthcare investment banking, equities, and equity research. Multiple Brookline Managing Directors previously held senior roles here, indicating a direct competitive overlap.
• Truist Securities: Mid-large full-service investment bank with a dedicated healthcare equity capital markets franchise. Competes with Brookline on healthcare IPOs, follow-ons, and ECM advisory from a broader platform perspective.
• Cowen and Company (TD Securities): Healthcare-focused investment bank (now part of TD Securities) historically known for biotech equity research and ECM. Direct competitor in healthcare capital markets where multiple Brookline Managing Partners previously held senior ECM roles.
• Lazard: Global advisory and asset management firm with a premier healthcare practice and deep equity capital markets franchise. Brookline's founder was formerly CEO of Lazard Capital Markets, and competes with Lazard on healthcare advisory and ECM mandates.
• Jefferies: Large full-service investment bank with a deep healthcare franchise and structured equity group. Competes with Brookline on healthcare IPOs, PIPEs, SPACs, and structured financings from a more diversified platform.

Emerging players

• EF Hutton: Emerging investment bank with a growing healthcare and life sciences capital markets franchise. Comparable as a smaller specialist competitor pursuing growth-stage healthcare issuers and equity research coverage.

Direct peers

• William Blair: Global investment bank with a large dedicated healthcare investment banking group covering biopharma and medical technology. Competes head-to-head with Brookline on healthcare ECM and advisory mandates across both public and private companies.
• BTIG: Employee-owned institutional brokerage and investment bank with a dedicated healthcare investment banking franchise. Highly comparable given direct overlap on healthcare ECM, follow-ons, and capital markets advisory where multiple Brookline Managing Partners previously led.
• Leerink Partners: Healthcare-focused investment bank providing advisory, equity capital markets, and equity research to life sciences companies. Direct competitor in the healthcare specialist boutique category where Brookline competes for mid-cap biotech mandates.
• Roth Capital Partners: Investment bank focused on small- and mid-cap companies with a strong healthcare and biotechnology research and capital markets franchise. Direct comparable in serving emerging and growth-stage healthcare issuers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/brookline-capital-markets

Revenue estimate

Valuation estimate

Number of profiles

Profiles22 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brookline Capital Markets